Evidence for the occurrence of depressant EEG effects after stimulation of dopamine D3 receptors: A computerized study in rabbits

Life Sciences

Volumn 59, Issue 21, 1996, Pages 1755-1761

  Popoli, P ^a   Pezzola A ^a   Reggio, R ^a   Scotti De Carolis, A ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

( )7 OH DPAT; D3 receptor agonist; EEG activation

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; BROMOCRIPTINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM DEPRESSION; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0030592550     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00518-8     Document Type: Article

References (22)

1. 1. P. SOKOLOFF, B. GIROS, M.P. MARTRES, M.L. BOUTHENET and J.C. SCHWARTZ, Nature 347 146-151 (1990).
2. 2. P. SOKOLOFF, M. ANDRIEUX, R. BESANCON, C. PILON, M.P. MARTRES, B. GIROS and J.C. SCHWARTZ, Eur. J. Pharmacol. (Mol. Pharmacol. Sect.) 225 331-337 (1992).
3. 3. D. LEVESQUE, J. DIAZ, C. PILON, M.P. MARTRES, B. GIROS, E. SOUIL, D. SCHOTT, J.L. MORGAT, J.C. SCHWARTZ and P. SOKOLOFF, Proc. Natl. Acad. Sci. USA 89 8155-8159 (1992).
4. 4. S.A. DALY and J.L. WADDINGTON, Neuropharmacology 32 509-510 (1993).
5. 5. S. AHLENIUS and P. SALMI, Eur. J. Pharmacol. 260 177-181 (1994).
6. 6. M. S. STARR and B.S. STARR, Eur. J. Pharmacol. 277 151-158 (1995).
7. 7. K. SVENSSON, A. CARLSSON and N. WATERS, J. Neural Transm. (Gen. Sect.) 95 71-74 (1994).
8. 8. K. SVENSSON, A. CARLSSON, R.M. HUFF, T.K. PETERSEN and N. WATERS, Eur. J. Pharmacol. 263 235-243 (1994).
9. 9. N. WATERS, K. SVENSSON, S.R. HAADSMA-SVENSSON, M.W. SMITH and A. CARLSSON, J. Neural Transm. (Gen. Sect.) 94 11-19 (1993).
10. 10. D. B. GILBERT and S.J. COOPER, Pharmacol. Biochem. Behav. 52 275-280 (1995).
11. 11. E. ONGINI and M.G. CAPORALI, Neuropharmacology 26 355-360 (1987).
12. 12. E. ONGINI and V.G. LONGO, Int. Rev. Neurobiol. 31 239-255 (1939).
13. 13. W. KROPF and K. KUSCHINSKY, Neuropharmacology 30 953-960 (1991).
14. 14. V.G. LONGO, Electroencephalographic Atlas for Pharmacological Research, Elsevier, Amsterdam (1962).
15. 15. F. SAUTEL, N. GRIFFON, D. LEVESQUE, C. PILON, J.C. SCHWARTZ and P. SOKOLOFF, NeuroReport 6 329-332 (1995).
16. 16. Official J. European Communities 29 1-27 (1986).
17. 17. B. DELBARRE, G. DELBARRE and F. CALINON, Soc. Neurosci. Abstr. 20 414 (1994).
18. 18. P.A. FLECKNELL, J.H. LILES and H.A. WILLIAMSON, Lab. Animals 24 142-146 (1990).
19. 19. M. VAN DE BUUSE, European J. Pharmacol. 243 169-177 (1993).
20. 20. A.M. GONZALES and D.R. SIBLEY, Eur. J. Pharmacol. 272 R1-R3 (1995).
21. 21. K. UVNAS-MOBERG, P. ALSTER, V. HILLEGAART and S. AHLENIUS, NeuroReport 6 1338-1340 (1995).
22. 22. J.M. MONTI, H. JANTOS and M. FERNANDEZ, Eur. J. Pharmacol. 169 61-66 (1989).